A San Francisco biotech is trying to cure HIV with the gene-editing tool CRISPR. Excision BioTherapeutics launched the first-ever CRISPR study for HIV patients on Thursday. The company's CEO hopes it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results